molecular operating environment (moe) version 2019 software Search Results


96
Molecular Devices LLC spectramax m3

Spectramax M3, supplied by Molecular Devices LLC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/SpectraMax+M3+Series+Microplate+Readers/pmc08299183-73-0-0
Average 96 stars, based on 1 article reviews
spectramax m3 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
Genovis Inc makerspace acorn co working space january

Makerspace Acorn Co Working Space January, supplied by Genovis Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/OpeRATOR+Lyophilized/10__1093_slash_cjres_slash_rsaf028-149-82-90
Average 93 stars, based on 1 article reviews
makerspace acorn co working space january - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

86
Molecular Dynamics Inc gromacs 2019 6 software

Gromacs 2019 6 Software, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/2019+6+gromacs/10__1016_slash_j__lwt__2025__118518-105-6-0
Average 86 stars, based on 1 article reviews
gromacs 2019 6 software - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
QUALISYS LIMITED qtm software

Qtm Software, supplied by QUALISYS LIMITED, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/qtm+software/pm38167926-216-21-25
Average 90 stars, based on 1 article reviews
qtm software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
Danaher Inc algorithm pclamp 11 2 software suite molecular devices

Algorithm Pclamp 11 2 Software Suite Molecular Devices, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/pCLAMP+11+Software+Suite/10__7554_slash_elife__79917-292-52-57
Average 96 stars, based on 1 article reviews
algorithm pclamp 11 2 software suite molecular devices - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

98
Jackson Immuno fitc conjugated goat anti mouse antibodies
FIG. 2. Anti-Spike antibodies trigger SARS-CoV infection of human Raji B cells. VeroE6 or human Raji cells were infected (MOI 1) with SARS-CoV strain HK39849 (SCoV) in the presence of either control or Anti-Spike serum for 1 h. Samples were fixed with 4% paraformaldehyde at 15 h postinfection. A mouse monoclonal antibody specific for the SCoV nucleocapsid (N) and rabbit polyclonal antibodies specific for SCoV membrane (M) protein were visualized using <t>TRITC-conjugated</t> goat anti-mouse and <t>FITC-conjugated</t> goat anti-rabbit antibodies, respectively. Cell nuclei were labeled with DAPI, and separate channel images were acquired. (A) As expected, SCoV infection of VeroE6 (I) was completely blocked by anti-Spike serum (1/500, II). (B) In contrast, SCoV viral proteins were detected in Raji cells only when they were incubated with anti-Spike (1/500, IV) but never with control serum (III). Quantification of infection (right-hand portions in panels A and B) was done by counting positive cells in 30 randomly chosen fields (630, final magnification), using Metamorph as described in Materials and Methods. The results are shown as means the SD of the number of fields.
Fitc Conjugated Goat Anti Mouse Antibodies, supplied by Jackson Immuno, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/Fluorescein+(FITC)+AffiniPure+Goat+Anti-Mouse+IgG/10__1128_slash_jvi__00671___11-91-20-24
Average 98 stars, based on 1 article reviews
fitc conjugated goat anti mouse antibodies - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

99
Gilead Sciences molnupiravir
A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and <t>Molnupiravir</t> before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.
Molnupiravir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/VEKLURY/pmc08777737-146-13-19
Average 99 stars, based on 1 article reviews
molnupiravir - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

86
Molecular Dynamics Inc desmond software
A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and <t>Molnupiravir</t> before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.
Desmond Software, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/desmond+software/10__56499_slash_jppres24__2216_13__s1__83-93-15-0
Average 86 stars, based on 1 article reviews
desmond software - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Chemical Computing Group moe version 2019 1
A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and <t>Molnupiravir</t> before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.
Moe Version 2019 1, supplied by Chemical Computing Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/0101+2019+moe/pm41075937-193-0-6
Average 86 stars, based on 1 article reviews
moe version 2019 1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Chemical Computing Group molecular operating environment moe software package version moe 2019 0102
A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and <t>Molnupiravir</t> before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.
Molecular Operating Environment Moe Software Package Version Moe 2019 0102, supplied by Chemical Computing Group, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/environment+molecular+operating/pm38471358-235-14-23
Average 86 stars, based on 1 article reviews
molecular operating environment moe software package version moe 2019 0102 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

96
Revvity attune nxt flow cytometer invitrogen
A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and <t>Molnupiravir</t> before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.
Attune Nxt Flow Cytometer Invitrogen, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/Celigo+image+cytometer/pm35588734-168-120-141
Average 96 stars, based on 1 article reviews
attune nxt flow cytometer invitrogen - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

98
Illumina Inc novaseq 6000
Viral mutation and infectivity of SARS-CoV-2.
Novaseq 6000, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/molecular+operating+environment+(moe)+version+2019+software/NovaSeq+6000+Installation+and+Operational+Qualification/pmc08232800-51-22-21
Average 98 stars, based on 1 article reviews
novaseq 6000 - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell Reports

Article Title: Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

doi: 10.1016/j.celrep.2021.109504

Figure Lengend Snippet:

Article Snippet: SpectraMax M3 , Molecular Devices, LLC , N/A.

Techniques: Recombinant, Biomarker Assay, Neutralization, Luciferase, Cell Culture, Lysis, Expressing, Software

FIG. 2. Anti-Spike antibodies trigger SARS-CoV infection of human Raji B cells. VeroE6 or human Raji cells were infected (MOI 1) with SARS-CoV strain HK39849 (SCoV) in the presence of either control or Anti-Spike serum for 1 h. Samples were fixed with 4% paraformaldehyde at 15 h postinfection. A mouse monoclonal antibody specific for the SCoV nucleocapsid (N) and rabbit polyclonal antibodies specific for SCoV membrane (M) protein were visualized using TRITC-conjugated goat anti-mouse and FITC-conjugated goat anti-rabbit antibodies, respectively. Cell nuclei were labeled with DAPI, and separate channel images were acquired. (A) As expected, SCoV infection of VeroE6 (I) was completely blocked by anti-Spike serum (1/500, II). (B) In contrast, SCoV viral proteins were detected in Raji cells only when they were incubated with anti-Spike (1/500, IV) but never with control serum (III). Quantification of infection (right-hand portions in panels A and B) was done by counting positive cells in 30 randomly chosen fields (630, final magnification), using Metamorph as described in Materials and Methods. The results are shown as means the SD of the number of fields.

Journal: Journal of Virology

Article Title: Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway

doi: 10.1128/jvi.00671-11

Figure Lengend Snippet: FIG. 2. Anti-Spike antibodies trigger SARS-CoV infection of human Raji B cells. VeroE6 or human Raji cells were infected (MOI 1) with SARS-CoV strain HK39849 (SCoV) in the presence of either control or Anti-Spike serum for 1 h. Samples were fixed with 4% paraformaldehyde at 15 h postinfection. A mouse monoclonal antibody specific for the SCoV nucleocapsid (N) and rabbit polyclonal antibodies specific for SCoV membrane (M) protein were visualized using TRITC-conjugated goat anti-mouse and FITC-conjugated goat anti-rabbit antibodies, respectively. Cell nuclei were labeled with DAPI, and separate channel images were acquired. (A) As expected, SCoV infection of VeroE6 (I) was completely blocked by anti-Spike serum (1/500, II). (B) In contrast, SCoV viral proteins were detected in Raji cells only when they were incubated with anti-Spike (1/500, IV) but never with control serum (III). Quantification of infection (right-hand portions in panels A and B) was done by counting positive cells in 30 randomly chosen fields (630, final magnification), using Metamorph as described in Materials and Methods. The results are shown as means the SD of the number of fields.

Article Snippet: The cells were then washed, and the primary antibody binding was revealed by staining at 4°C for 30 min with FITC-conjugated goat anti-mouse antibodies (Jackson Immunoresearch).

Techniques: Infection, Control, Membrane, Labeling, Incubation

FIG. 5. Blockade of FcRII abrogates antibody-mediated infection of human immune cell lines. (A) Total RNAs from the indicated cell lines were extracted for RT-PCR amplification as described under Materials and Methods. cDNAs and negative RT controls (RT) were probed for detection of FcεR1-chain, FcRIA (CD64a), FcRIIA (CD32a), FcRIIB (CD32b), FcRIIIA (CD16a), ACE2, and GAPDH. DNA plasmids containing the coding sequence of the human Fc receptors or the human ACE2 (104 and 106 copies) were used as positive controls. Amplicons were visualized by ethidium bromide staining after agarose gel electrophoresis. For reference, a 1-kb molecular-weight standard is also shown. Due to the murine origin of the macrophage-like P388D1 and J774A.1 cell lines and because the primers were designed for the detection of human FcR (Table 2), no FcR transcripts were detected in P388D1 and J774A.1 cells. (B) Hematopoietic cell lines displaying a detectable level of FcR transcript in panel A were subjected to flow cytometry. Cell lines were stained with either isotype-matched control antibody (gray-filled histograms) or FcR-specific mouse monoclonal antibody (open histograms) as indicated, followed by secondary FITC-conjugated goat anti-mouse antibodies. Labeled samples were then read by flow cytometry and post-acquisition analysis was performed using FlowJo software. Insets show the median of fluorescence intensity of the anti-FcR staining. When not visible, the open histograms were superimposed on the gray-filled ones. The data are representative of two independent experiments with similar results. (C) Effect of FcR blockage on susceptibility of the cells to ADE infection. Prior to infection, cells were treated with anti-FcR blocking antibodies. At 3 days postinfection, luciferase substrate reagent was added to wells, and the luminescence was measured. The data were normalized to control conditions, viz., cells infected in the presence of IgG isotype-matched control antibody, and expressed as a percentage of the changes in luminescence. For all conditions, values of background luminescence (never exceeding 3% of control) were subtracted prior to normalization. The results are the means the SD of nine measurements from three independent experiments. ‡, P 0.05; *, P 0.001 (unpaired Student t test).

Journal: Journal of Virology

Article Title: Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway

doi: 10.1128/jvi.00671-11

Figure Lengend Snippet: FIG. 5. Blockade of FcRII abrogates antibody-mediated infection of human immune cell lines. (A) Total RNAs from the indicated cell lines were extracted for RT-PCR amplification as described under Materials and Methods. cDNAs and negative RT controls (RT) were probed for detection of FcεR1-chain, FcRIA (CD64a), FcRIIA (CD32a), FcRIIB (CD32b), FcRIIIA (CD16a), ACE2, and GAPDH. DNA plasmids containing the coding sequence of the human Fc receptors or the human ACE2 (104 and 106 copies) were used as positive controls. Amplicons were visualized by ethidium bromide staining after agarose gel electrophoresis. For reference, a 1-kb molecular-weight standard is also shown. Due to the murine origin of the macrophage-like P388D1 and J774A.1 cell lines and because the primers were designed for the detection of human FcR (Table 2), no FcR transcripts were detected in P388D1 and J774A.1 cells. (B) Hematopoietic cell lines displaying a detectable level of FcR transcript in panel A were subjected to flow cytometry. Cell lines were stained with either isotype-matched control antibody (gray-filled histograms) or FcR-specific mouse monoclonal antibody (open histograms) as indicated, followed by secondary FITC-conjugated goat anti-mouse antibodies. Labeled samples were then read by flow cytometry and post-acquisition analysis was performed using FlowJo software. Insets show the median of fluorescence intensity of the anti-FcR staining. When not visible, the open histograms were superimposed on the gray-filled ones. The data are representative of two independent experiments with similar results. (C) Effect of FcR blockage on susceptibility of the cells to ADE infection. Prior to infection, cells were treated with anti-FcR blocking antibodies. At 3 days postinfection, luciferase substrate reagent was added to wells, and the luminescence was measured. The data were normalized to control conditions, viz., cells infected in the presence of IgG isotype-matched control antibody, and expressed as a percentage of the changes in luminescence. For all conditions, values of background luminescence (never exceeding 3% of control) were subtracted prior to normalization. The results are the means the SD of nine measurements from three independent experiments. ‡, P 0.05; *, P 0.001 (unpaired Student t test).

Article Snippet: The cells were then washed, and the primary antibody binding was revealed by staining at 4°C for 30 min with FITC-conjugated goat anti-mouse antibodies (Jackson Immunoresearch).

Techniques: Infection, Reverse Transcription Polymerase Chain Reaction, Sequencing, Staining, Agarose Gel Electrophoresis, Molecular Weight, Cytometry, Control, Labeling, Software, Blocking Assay, Luciferase

FIG. 6. Human FcRIIA and B1, but not huFcRIA nor huFcRIIIA, are responsible for ADE of SARS-CoV pseudoparticles (SARS-CoVpp) infection. (A) Human Raji, parental, and monoclonal FcR-transduced human ST486 B cell lines were stained with either isotype-matched control antibody (gray-tinted histogram) or FcR-specific mouse monoclonal antibody (open histogram) as indicated, followed by secondary FITC- conjugated goat anti-mouse antibodies. Labeled samples were then read by flow cytometry and postacquisition analysis was performed using FlowJo software. The inset shows the median of fluorescence intensity of the anti-FcR staining. When not visible, the open histograms were superimposed on the gray-filled ones. (B) Potency of FcR(s) to trigger antibody-mediated entry of SARS-CoVpp was assessed by using ST486 cell lines stably expressing a single FcR. SARS-CoVpp were incubated in the presence or absence of different dilutions (1/1,000, 1/2,000, and 1/4,000) of either control (solid bars) or anti-Spike (hatched bars) serum for 1 h prior to addition to the cells. At 3 days postinfection, luciferase substrate reagent was added to wells, and the luminescence was measured. The data were normalized to control conditions, viz., cells incubated with SARS-CoVpp in the absence of any serum (black bar, taken as unity) and expressed as fold changes in luminescence. Because results for SARS-CoVpp control serum were virtually identical with all cell lines, for the sake of clarity only one dilution (1/4,000) is shown. The results are the means the SD of nine measurements from three independent experiments. Statistical significance was assessed by comparing the appropriate dilutions of mock and anti-Spike serum. ‡, P 0.05; *, P 0.01 (unpaired Student t test).

Journal: Journal of Virology

Article Title: Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway

doi: 10.1128/jvi.00671-11

Figure Lengend Snippet: FIG. 6. Human FcRIIA and B1, but not huFcRIA nor huFcRIIIA, are responsible for ADE of SARS-CoV pseudoparticles (SARS-CoVpp) infection. (A) Human Raji, parental, and monoclonal FcR-transduced human ST486 B cell lines were stained with either isotype-matched control antibody (gray-tinted histogram) or FcR-specific mouse monoclonal antibody (open histogram) as indicated, followed by secondary FITC- conjugated goat anti-mouse antibodies. Labeled samples were then read by flow cytometry and postacquisition analysis was performed using FlowJo software. The inset shows the median of fluorescence intensity of the anti-FcR staining. When not visible, the open histograms were superimposed on the gray-filled ones. (B) Potency of FcR(s) to trigger antibody-mediated entry of SARS-CoVpp was assessed by using ST486 cell lines stably expressing a single FcR. SARS-CoVpp were incubated in the presence or absence of different dilutions (1/1,000, 1/2,000, and 1/4,000) of either control (solid bars) or anti-Spike (hatched bars) serum for 1 h prior to addition to the cells. At 3 days postinfection, luciferase substrate reagent was added to wells, and the luminescence was measured. The data were normalized to control conditions, viz., cells incubated with SARS-CoVpp in the absence of any serum (black bar, taken as unity) and expressed as fold changes in luminescence. Because results for SARS-CoVpp control serum were virtually identical with all cell lines, for the sake of clarity only one dilution (1/4,000) is shown. The results are the means the SD of nine measurements from three independent experiments. Statistical significance was assessed by comparing the appropriate dilutions of mock and anti-Spike serum. ‡, P 0.05; *, P 0.01 (unpaired Student t test).

Article Snippet: The cells were then washed, and the primary antibody binding was revealed by staining at 4°C for 30 min with FITC-conjugated goat anti-mouse antibodies (Jackson Immunoresearch).

Techniques: Infection, Staining, Control, Labeling, Cytometry, Software, Stable Transfection, Expressing, Incubation, Luciferase

A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and Molnupiravir before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: A schematic 2D LIGPLOT (LIGPLOT software is a program to generate schematic diagrams of protein-ligand interactions) representation showing 3a–f , Remdesivir, and Molnupiravir before and after docking into the binding pocket of 7BQY. The variations in the ligands are highlighted by yellow circles.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques: Software, Binding Assay

A schematic 2D LIGPLOT representation of Molnupiravir and 3b against the complex 7BQY showing the hydrogen and hydrophobic interactions.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: A schematic 2D LIGPLOT representation of Molnupiravir and 3b against the complex 7BQY showing the hydrogen and hydrophobic interactions.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques:

Box plot representing the comparison between hydrogen and hydrophobic bonds among the amino acid residues of the COVID-19 M pro substrate-binding pocket produced by docking with the six newly synthesized ligands 3a–f , Remdesivir, and Molnupiravir.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Box plot representing the comparison between hydrogen and hydrophobic bonds among the amino acid residues of the COVID-19 M pro substrate-binding pocket produced by docking with the six newly synthesized ligands 3a–f , Remdesivir, and Molnupiravir.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques: Binding Assay, Produced, Synthesized

Means and SDs of the binding affinities of the nine docking poses for compounds against the COVID-19 main protease 7BQY.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Means and SDs of the binding affinities of the nine docking poses for compounds against the COVID-19 main protease 7BQY.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques: Binding Assay

Acute oral toxicity predicted by the ProTox-II web server for ligands 3a–f and the approved drugs.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Acute oral toxicity predicted by the ProTox-II web server for ligands 3a–f and the approved drugs.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques:

Organ toxicity and toxicological endpoints-predicted activity calculated using the ProTox-II web server for ligands 3a–f ,  Molnupiravir,  and Remdesivir.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Organ toxicity and toxicological endpoints-predicted activity calculated using the ProTox-II web server for ligands 3a–f , Molnupiravir, and Remdesivir.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques: Activity Assay

Physicochemical properties and lipophilicity of ligands 3a–f in comparison with the approved drugs  Molnupiravir  and Remdesivir.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Physicochemical properties and lipophilicity of ligands 3a–f in comparison with the approved drugs Molnupiravir and Remdesivir.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques: Molecular Weight

Bioavailability radar for ligands 3a–f and the approved drugs Molnupiravir and Remdesivir.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: Bioavailability radar for ligands 3a–f and the approved drugs Molnupiravir and Remdesivir.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques:

The pharmacokinetics properties of ligands 3a–f in comparison with those of the approved drugs,  Molnupiravir  and Remdesivir.

Journal: Molecules

Article Title: Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological Study

doi: 10.3390/molecules27020488

Figure Lengend Snippet: The pharmacokinetics properties of ligands 3a–f in comparison with those of the approved drugs, Molnupiravir and Remdesivir.

Article Snippet: However, the TSAP of 3b was 144.26 Å 2 closer to that of Molnupiravir (143.14 Å 2 ), whereas Remdesivir showed the most significant value (213.36 Å 2 ).

Techniques:

Viral mutation and infectivity of SARS-CoV-2.

Journal: Journal of Clinical Medicine

Article Title: SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence

doi: 10.3390/jcm10122635

Figure Lengend Snippet: Viral mutation and infectivity of SARS-CoV-2.

Article Snippet: [ ] , Uruguay , March to May 2020 , 44 , Naso-oropharyngeal swabs , Whole SARS-CoV-2 genomes were sequenced using Illumina NovaSeq 6000 , D614G mutation , The spike D614G mutation and clade G-related viruses were not associated with any clinical parameters, severity, or lethality of COVID-19 infection.

Techniques: Mutagenesis, Infection, Sequencing, In Vitro, Animal Model, Variant Assay, Transmission Assay, Expressing, Produced, In Vivo, In Silico, Software, Binding Assay, Amplification

Viral mutation and severity of COVID-19.

Journal: Journal of Clinical Medicine

Article Title: SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence

doi: 10.3390/jcm10122635

Figure Lengend Snippet: Viral mutation and severity of COVID-19.

Article Snippet: [ ] , Uruguay , March to May 2020 , 44 , Naso-oropharyngeal swabs , Whole SARS-CoV-2 genomes were sequenced using Illumina NovaSeq 6000 , D614G mutation , The spike D614G mutation and clade G-related viruses were not associated with any clinical parameters, severity, or lethality of COVID-19 infection.

Techniques: Mutagenesis, Sequencing, Variant Assay, Infection, Generated, Cell Counting, Next-Generation Sequencing, Amplification, Labeling, Animal Model, Isolation, Selection, Genomic Sequencing, Diagnostic Assay, Real-time Polymerase Chain Reaction, Construct, Software